Eidos Therapeutics
SAN FRANCISCO, CA · Founded 2013 · CIK 0001731831 · Biotech · Acquired
Acoramidis, a transthyretin stabilizer molecule for treating ATTR amyloidosis
eidostx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $26M
- 1 Form D · Apr 2018
- 102 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 29
- 8 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $26,047,857 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2457 | LIFESPLICE PHARMA, LLC | — | — |
| 2458 | ImmusanT, Inc. | — | $33M |
| 2459 | GALECTIN THERAPEUTICS INC | — | $6.8M |
| 2460 | Eidos Therapeutics | — | $26M |
| 2461 | Expesicor Inc | — | — |
| 2462 | Actym Therapeutics, Inc. | — | $25M |
| 2463 | Verseon Corp | — | $25M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- ERIC AGUIARDirector
- JONATHAN FOXExecutive Officer
- HOYOUNG HUHDirector
- NEIL KUMARDirector · Executive Officer
- RAJEEV SHAHDirector
- UMA SINHAExecutive Officer
- CHRISTINE SIUExecutive Officer
Patents
- Formulations Of AG10application
- Formulations Of AG10granted
- Processes For Preparing AG-10, Its Intermediates, And Salts Thereofapplication
- Methods Of Treating Ttr Amyloidosis Using AG10application
- Methods Of Treating Ttr Amyloidosis Using AG10granted
- Processes For Preparing AG-10, Its Intermediates, And Salts Thereofapplication
- Formulations Of AG10granted
- Processes For Preparing AG-10, Its Intermediates, And Salts Thereofgranted
- Formulations Of AG10granted
- Processes For Preparing AG-10, Its Intermediates, And Salts Thereofgranted
- Methods Of Treating Ttr Amyloidosis Using AG10granted
- Processes For Preparing AG-10, Its Intermediates, and Salts Thereofgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.